Opioids Addiction Prevention Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Opioids Addiction Prevention Market: Drug Type (Naloxone, Buprenorphine, Methadone), Treatment Centers (Residential Treatment Centers, Outpatient Treatment Centers, Inpatient Treatment Centers), Route of Administration (Oral, Parental), Distribution Channel (Retail Pharmacies, Hospitals, Rehabilitation Centers), and Geography

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

1. Executive Summary
2. Global Opioids Addiction Prevention Market Introduction
2.1. Global Opioids Addiction Prevention Market – Taxonomy
2.2. Global Opioids Addiction Prevention Market –Definitions
2.2.1. Drug Type
2.2.2. Treatment Centers
2.2.3. Route of Administration
2.2.4. Distribution Channel
2.2.5. Region
3. Global Opioids Addiction Prevention Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Opioids Addiction Prevention Market Dynamic Factors – Impact Analysis
3.6. Impact of COVID 19 on The Market
3.7. Three Forecast Scenarios – Pessimistic, Conservative and Opportunistic
3.8. Mapping Market Players Activities
3.9. Recent Key Developments
3.10. Financial Status of the Market Players
3.11. Recent Acquisitions, Collaborations and Mergers
4. Global Opioids Addiction Prevention Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Opioids Addiction Prevention Market Forecast, By Drug Type, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.1. Naloxone
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Buprenorphine
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Methadone
5.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. Global Opioids Addiction Prevention Market Forecast, By Treatment Centers, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.1. Residential Treatment Centers
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Outpatient Treatment Centers
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Inpatient Treatment Centers
6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. Market Opportunity Analysis Global Opioids Addiction Prevention Market Forecast, By Route of Administration, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
7.1. Oral
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Parental
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
8. Market Opportunity Analysis Global Opioids Addiction Prevention Market Forecast, By Distribution Channel, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
8.1. Retail Pharmacies
8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Hospitals
8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Rehabilitation Centers
8.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
9. Global Opioids Addiction Prevention Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
9.1. North America
9.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Opioids Addiction Prevention Market – Opportunity Analysis Index, By Drug Type, Treatment Centers, Route of Administration, Distribution Channel, and Region, 2022 – 2028
10. North America Opioids Addiction Prevention Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
10.1. Drug Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Naloxone
10.1.2. Buprenorphine
10.1.3. Methadone
10.2. Treatment Centers Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Residential Treatment Centers
10.2.2. Outpatient Treatment Centers
10.2.3. Inpatient Treatment Centers
10.3. Route of Administration Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Oral
10.3.2. Parental
10.4. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
10.4.1. Retail Pharmacies
10.4.2. Hospitals
10.4.3. Rehabilitation Centers
10.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
10.5.1. U.S.
10.5.2. Canada
10.6. North America Opioids Addiction Prevention Market – Opportunity Analysis Index, By Drug Type, Route of Administration and Country, 2022 – 2028
10.7. North America Opioids Addiction Prevention Market Dynamics – Trends
11. Europe Opioids Addiction Prevention Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
11.1. Drug Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
11.1.1. Naloxone
11.1.2. Buprenorphine
11.1.3. Methadone
11.2. Treatment Centers Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Residential Treatment Centers
11.2.2. Outpatient Treatment Centers
11.2.3. Inpatient Treatment Centers
11.3. Route of Administration Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Oral
11.3.2. Parental
11.4. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Retail Pharmacies
11.4.2. Hospitals
11.4.3. Rehabilitation Centers
11.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Europe Opioids Addiction Prevention Market – Opportunity Analysis Index, By Drug Type, Route of Administration and Country, 2022 – 2028
11.7. Europe Opioids Addiction Prevention Market Dynamics – Trends
12. Asia-Pacific Opioids Addiction Prevention Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
12.1. Drug Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
12.1.1. Naloxone
12.1.2. Buprenorphine
12.1.3. Methadone
12.2. Treatment Centers Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Residential Treatment Centers
12.2.2. Outpatient Treatment Centers
12.2.3. Inpatient Treatment Centers
12.3. Route of Administration Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Oral
12.3.2. Parental
12.4. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Retail Pharmacies
12.4.2. Hospitals
12.4.3. Rehabilitation Centers
12.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. ASEAN
12.5.5. Rest of Asia-Pacific
12.6. Asia-Pacific Opioids Addiction Prevention Market – Opportunity Analysis Index, By Drug Type, Route of Administration and Country, 2022 – 2028
12.7. Asia-Pacific Opioids Addiction Prevention Market Dynamics – Trends
13. Latin America Opioids Addiction Prevention Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
13.1. Drug Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
13.1.1. Naloxone
13.1.2. Buprenorphine
13.1.3. Methadone
13.2. Treatment Centers Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Residential Treatment Centers
13.2.2. Outpatient Treatment Centers
13.2.3. Inpatient Treatment Centers
13.3. Route of Administration Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Oral
13.3.2. Parental
13.4. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Retail Pharmacies
13.4.2. Hospitals
13.4.3. Rehabilitation Centers
13.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Argentina
13.5.3. Rest of Latin America
13.6. Latin America Opioids Addiction Prevention Market – Opportunity Analysis Index, By Drug Type, Route of Administration and Country, 2022 – 2028
13.7. Latin America Opioids Addiction Prevention Market Dynamics – Trends
14. Middle East and Africa Opioids Addiction Prevention Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
14.1. Drug Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
14.1.1. Naloxone
14.1.2. Buprenorphine
14.1.3. Methadone
14.2. Treatment Centers Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
14.2.1. Residential Treatment Centers
14.2.2. Outpatient Treatment Centers
14.2.3. Inpatient Treatment Centers
14.3. Route of Administration Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Oral
14.3.2. Parental
14.4. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Retail Pharmacies
14.4.2. Hospitals
14.4.3. Rehabilitation Centers
14.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Saudi Arabia
14.5.2. GCC Countries
14.5.3. South Africa
14.5.4. Rest of MEA
14.6. MEA Opioids Addiction Prevention Market – Opportunity Analysis Index, By Drug Type, Route of Administration and Country, 2022 – 2028
14.7. MEA Opioids Addiction Prevention Market Dynamics – Trends
15. Competition Landscape 
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Drug Type Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Omeros
15.2.2. Camurus
15.2.3. Orexo
15.2.4. MediciNova
15.2.5. Teva Pharmaceuticals
15.2.6.  Hikma Pharmaceuticals
15.2.7. Reckitt Benckiser Pharmaceuticals, Inc.
15.2.8. Mylan
15.2.9. Dr. Reddy’s Laboratories
15.2.10. Addinex Technologies, Inc.
15.2.11. Indivior
15.2.12. Alkermes
15.2.13. Titan Pharmaceuticals
16. Research Methodology
17. Key Assumptions and Acronyms

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Company Profile

 

  • Omeros
  • Camurus
  • Orexo
  • MediciNova
  • Teva Pharmaceuticals
  • Hikma Pharmaceuticals
  • Reckitt Benckiser Pharmaceuticals, Inc.
  • Mylan
  • Dr. Reddy’s Laboratories
  • Addinex Technologies, Inc.
  • Indivior
  • Alkermes
  • Titan Pharmaceuticals

Description

1. Executive Summary
2. Global Opioids Addiction Prevention Market Introduction
2.1. Global Opioids Addiction Prevention Market – Taxonomy
2.2. Global Opioids Addiction Prevention Market –Definitions
2.2.1. Drug Type
2.2.2. Treatment Centers
2.2.3. Route of Administration
2.2.4. Distribution Channel
2.2.5. Region
3. Global Opioids Addiction Prevention Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Opioids Addiction Prevention Market Dynamic Factors – Impact Analysis
3.6. Impact of COVID 19 on The Market
3.7. Three Forecast Scenarios – Pessimistic, Conservative and Opportunistic
3.8. Mapping Market Players Activities
3.9. Recent Key Developments
3.10. Financial Status of the Market Players
3.11. Recent Acquisitions, Collaborations and Mergers
4. Global Opioids Addiction Prevention Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Opioids Addiction Prevention Market Forecast, By Drug Type, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.1. Naloxone
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Buprenorphine
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Methadone
5.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. Global Opioids Addiction Prevention Market Forecast, By Treatment Centers, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.1. Residential Treatment Centers
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Outpatient Treatment Centers
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Inpatient Treatment Centers
6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. Market Opportunity Analysis Global Opioids Addiction Prevention Market Forecast, By Route of Administration, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
7.1. Oral
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Parental
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
8. Market Opportunity Analysis Global Opioids Addiction Prevention Market Forecast, By Distribution Channel, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
8.1. Retail Pharmacies
8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Hospitals
8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Rehabilitation Centers
8.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
9. Global Opioids Addiction Prevention Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
9.1. North America
9.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Opioids Addiction Prevention Market – Opportunity Analysis Index, By Drug Type, Treatment Centers, Route of Administration, Distribution Channel, and Region, 2022 – 2028
10. North America Opioids Addiction Prevention Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
10.1. Drug Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Naloxone
10.1.2. Buprenorphine
10.1.3. Methadone
10.2. Treatment Centers Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Residential Treatment Centers
10.2.2. Outpatient Treatment Centers
10.2.3. Inpatient Treatment Centers
10.3. Route of Administration Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Oral
10.3.2. Parental
10.4. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
10.4.1. Retail Pharmacies
10.4.2. Hospitals
10.4.3. Rehabilitation Centers
10.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
10.5.1. U.S.
10.5.2. Canada
10.6. North America Opioids Addiction Prevention Market – Opportunity Analysis Index, By Drug Type, Route of Administration and Country, 2022 – 2028
10.7. North America Opioids Addiction Prevention Market Dynamics – Trends
11. Europe Opioids Addiction Prevention Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
11.1. Drug Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
11.1.1. Naloxone
11.1.2. Buprenorphine
11.1.3. Methadone
11.2. Treatment Centers Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Residential Treatment Centers
11.2.2. Outpatient Treatment Centers
11.2.3. Inpatient Treatment Centers
11.3. Route of Administration Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Oral
11.3.2. Parental
11.4. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Retail Pharmacies
11.4.2. Hospitals
11.4.3. Rehabilitation Centers
11.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Europe Opioids Addiction Prevention Market – Opportunity Analysis Index, By Drug Type, Route of Administration and Country, 2022 – 2028
11.7. Europe Opioids Addiction Prevention Market Dynamics – Trends
12. Asia-Pacific Opioids Addiction Prevention Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
12.1. Drug Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
12.1.1. Naloxone
12.1.2. Buprenorphine
12.1.3. Methadone
12.2. Treatment Centers Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Residential Treatment Centers
12.2.2. Outpatient Treatment Centers
12.2.3. Inpatient Treatment Centers
12.3. Route of Administration Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Oral
12.3.2. Parental
12.4. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Retail Pharmacies
12.4.2. Hospitals
12.4.3. Rehabilitation Centers
12.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. ASEAN
12.5.5. Rest of Asia-Pacific
12.6. Asia-Pacific Opioids Addiction Prevention Market – Opportunity Analysis Index, By Drug Type, Route of Administration and Country, 2022 – 2028
12.7. Asia-Pacific Opioids Addiction Prevention Market Dynamics – Trends
13. Latin America Opioids Addiction Prevention Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
13.1. Drug Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
13.1.1. Naloxone
13.1.2. Buprenorphine
13.1.3. Methadone
13.2. Treatment Centers Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Residential Treatment Centers
13.2.2. Outpatient Treatment Centers
13.2.3. Inpatient Treatment Centers
13.3. Route of Administration Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Oral
13.3.2. Parental
13.4. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Retail Pharmacies
13.4.2. Hospitals
13.4.3. Rehabilitation Centers
13.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Argentina
13.5.3. Rest of Latin America
13.6. Latin America Opioids Addiction Prevention Market – Opportunity Analysis Index, By Drug Type, Route of Administration and Country, 2022 – 2028
13.7. Latin America Opioids Addiction Prevention Market Dynamics – Trends
14. Middle East and Africa Opioids Addiction Prevention Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
14.1. Drug Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
14.1.1. Naloxone
14.1.2. Buprenorphine
14.1.3. Methadone
14.2. Treatment Centers Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
14.2.1. Residential Treatment Centers
14.2.2. Outpatient Treatment Centers
14.2.3. Inpatient Treatment Centers
14.3. Route of Administration Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Oral
14.3.2. Parental
14.4. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Retail Pharmacies
14.4.2. Hospitals
14.4.3. Rehabilitation Centers
14.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Saudi Arabia
14.5.2. GCC Countries
14.5.3. South Africa
14.5.4. Rest of MEA
14.6. MEA Opioids Addiction Prevention Market – Opportunity Analysis Index, By Drug Type, Route of Administration and Country, 2022 – 2028
14.7. MEA Opioids Addiction Prevention Market Dynamics – Trends
15. Competition Landscape 
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Drug Type Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Omeros
15.2.2. Camurus
15.2.3. Orexo
15.2.4. MediciNova
15.2.5. Teva Pharmaceuticals
15.2.6.  Hikma Pharmaceuticals
15.2.7. Reckitt Benckiser Pharmaceuticals, Inc.
15.2.8. Mylan
15.2.9. Dr. Reddy’s Laboratories
15.2.10. Addinex Technologies, Inc.
15.2.11. Indivior
15.2.12. Alkermes
15.2.13. Titan Pharmaceuticals
16. Research Methodology
17. Key Assumptions and Acronyms

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX